Výsledky vyhledávání - "Jolien T. M. Mensink"

Case report. 71-jarige man met progressieve onderbuikspijn en onvermogen tot mictie

Autor: Frank M. Zijta, Tan Q. T. Tong, Jolien T. M. Mensink

Publikováno v: Tijdschrift voor Urologie. 11:76-79

SamenvattingDeze casus beschrijft een patiënt met progressieve onderbuikspijn en onvermogen tot mictie op basis van een uitzonderlijk grote mediane intraprostatische cyste. Een dergelijke cyste is een zeldzame, benigne, vaak asymptomatische aandoeni

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7573856bd3e9cff20d5a12aaf196611f
https://doi.org/10.1007/s13629-021-00325-y

Zobrazit plný text záznamu

Plný text ve formátu HTML

T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at Diagnosis

Autor: Jolien T. M. Mensink, Ellen C. Zwarthoff, Tahlita C.M. Zuiverloon, Joep J. de Jong, Vebjørn Kvikstad, Deric K. Van der Schoot, Florus C. de Jong, Joost L. Boormans, Robert F. Hoedemaeker, Egbert R. Boevé

Publikováno v: Journal of Urology, 205(3), 701-708. Elsevier Inc.
Journal of Urology

PURPOSE: Currently, markers are lacking that can identify patients with high risk nonmuscle invasive bladder cancer who will fail bacillus Calmette-Guérin treatment. Therefore, we evaluated the prognostic value of T1 substaging in patients with prim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53ac3041abb56f6e466acad8828dad81
https://doi.org/10.1097/ju.0000000000001422

Zobrazit plný text záznamu

MP66-01 RNA-SEQUENCING OF BCG TREATED BLADDER CANCER PATIENTS IDENTIFIES PATIENTS WITH AGGRESSIVE AND IMMUNE SUPPRESSIVE TUMORS AT RISK OF BCG FAILURE

Autor: Tahlita C.M. Zuiverloon, Sébastien Rinaldetti, Ellen C. Zwarthoff, James C. Costello, Joep J. de Jong, Dan Theodorescu, Robert F. Hoedemaeker, Teemu D. Laajala, Angelique C. van der Made, Egbert R. Boevé, Florus C. de Jong, Jolien T. M. Mensink, Joost L. Boormans, Deric K. Van der Schoot

Publikováno v: Journal of Urology. 206

INTRODUCTION AND OBJECTIVE:Intravesical Bacillus Calmette-Guerin (BCG) is the recommended treatment option in high-risk non-muscle invasive bladder cancer (HR-NMIBC). However, disease recurrence oc...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fc287759ac399e12a07c67e98fec3f40
https://doi.org/10.1097/ju.0000000000002106.01

Zobrazit plný text záznamu

Transcriptome sequencing of BCG-treated T1HG bladder cancer patients identifies an EMT-basal subgroup with immune suppressive characteristics at high risk of BCG failure

Autor: D.K.E. Schoot, Teemu D. Laajala, Ellen C. Zwarthoff, Joost L. Boormans, F.C. De Jong, James C. Costello, Sébastien Rinaldetti, A.C.J. Van Der Made, Egbert R. Boevé, Tahlita C.M. Zuiverloon, Dan Theodorescu, Robert F. Hoedemaeker, Jolien T. M. Mensink

Publikováno v: European Urology. 79:S612-S613

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4fd5fda67d8c783ce357fe58d414ceed
https://doi.org/10.1016/s0302-2838(21)00825-3

Zobrazit plný text záznamu

Abstract 614: Transcriptomic analysis of BCG-treated T1HG bladder cancer patients identifies an EMT-basal subgroup with immune suppressive characteristics at high risk of BCG-failure

Autor: Joost L. Boormans, Sébastien Rinaldetti, E.C. Zwarthoff, Florus C. de Jong, Deric K. Van der Schoot, Jolien T. M. Mensink, Dan Theodorescu, Teemu D. Laajala, Angelique C. van der Made, Egbert R. Boevé, Robert F. Hoedemaeker, James C. Costello, Tahlita C.M. Zuiverloon

Publikováno v: Cancer Research. 81:614-614

Intravesical instillations with Bacillus Calmette-Guérin (BCG) are the recommended treatment in T1 high-grade (HG) bladder cancer (BC) patients. However, even with BCG treatment, 50% of patients develop a HG recurrence or progression to advanced dis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::87919f68e9e7a0c8f8fc0778f072e9c6
https://doi.org/10.1158/1538-7445.am2021-614

Zobrazit plný text záznamu

Abstract 615: Differential pathway analyses of BCG-treated T1HG bladder cancer using Philips OncoSignal: A pilot study

Autor: Teemu D. Laajala, Sébastien Rinaldetti, Robert F. Hoedemaeker, Deric K. Van der Schoot, Angelique C. van der Made, Tahlita C.M. Zuiverloon, Florus C. de Jong, Joost L. Boormans, Egbert R. Boevé, E.C. Zwarthoff, Dan Theodorescu, James C. Costello, Jolien T. M. Mensink

Publikováno v: Cancer Research. 81:615-615

Intravesical instillations with Bacillus Calmette-Guérin (BCG) is the recommended treatment for T1 high-grade (HG) bladder cancer (BC) patients. Unfortunately, risk stratification is insufficient to identify patients at risk of BCG treatment failure

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3d85c7efa6119afa38af54dbffd4d09c
https://doi.org/10.1158/1538-7445.am2021-615

Zobrazit plný text záznamu

Abstract B06: Pathologic T1 substaging improves the identification of high-risk non-muscle invasive bladder cancer patients at risk of BCG failure

Autor: Vebjørn Kvikstad, Jolien T. M. Mensink, Deric K. Van der Schoot, Florus C. de Jong, Tahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Egbert R. Boevé, Robert F. Hoedemaeker

Publikováno v: Clinical Cancer Research. 26:B06-B06

Introduction: High-risk non-muscle invasive bladder cancer (HR-NMIBC) patients represent a challenging group as they have the highest risk of treatment failure despite transurethral tumor resection (TUR) and adjuvant intravesical Bacillus Calmette-Gu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::969178903ec50fa34a53c30bb5bdb2fb
https://doi.org/10.1158/1557-3265.bladder19-b06

Zobrazit plný text záznamu

Definitions of BCG-failure (EAU) vs BCG-unresponsive (FDA) in high-risk non-muscle invasive bladder cancer: A comparison of patient outcome

Autor: Vebjørn Kvikstad, D.K.E. Van Der Schoot, Jolien T. M. Mensink, Tahlita C.M. Zuiverloon, Robert F. Hoedemaeker, E.C. Zwarthoff, Joost L. Boormans, Egbert R. Boevé, F.C. De Jong

Publikováno v: European Urology Open Science, Vol 19, Iss, Pp e1171-(2020)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c46ad9e5ceef1542d3fa2e2e8a618db
https://doi.org/10.1016/s2666-1683(20)33370-x

Zobrazit plný text záznamu

Pathological T1 substaging corresponds with BCG-failure and improves the current EAU risk stratification for non-muscle invasive bladder cancer patients

Autor: F.C. De Jong, Vebjørn Kvikstad, Tahlita C.M. Zuiverloon, D.K.E. Van Der Schoot, Joost L. Boormans, Robert F. Hoedemaeker, Jolien T. M. Mensink, E.C. Zwarthoff, Egbert R. Boevé

Publikováno v: European Urology Open Science, Vol 19, Iss, Pp e1419-(2020)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7286ea3a34afccab2d17ce5f1bc137b4
https://doi.org/10.1016/s2666-1683(20)33536-9

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání